Announcements Trials
Browse Landscape

Phase

Phase 2 69Phase 1 27Phase 3 19Phase 1/2 17Phase NA 7Phase 2/3 3Phase EARLY_PHASE1 1

Status

Completed 2Active not recruiting 1

Sponsor Class

INDUSTRY 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 3Plasma cell 1

Conditions

Sarcoma 10Osteosarcoma 5Bone Neoplasms 5Neurofibrosarcoma 3Neoplasms 3Lung Neoplasms 3Liposarcoma 3Leiomyosarcoma 3Sarcoma, Synovial 2Sarcoma, Ewing 2Sarcoma, Alveolar Soft Part 2Nerve Sheath Neoplasms 2Neoplasm Metastasis 2Lymphoma 2Histiocytoma, Malignant Fibrous 2Gliosarcoma 2Gastrointestinal Stromal Tumors 2Fibrosarcoma 2Chondrosarcoma, Extraskeletal Myxoid 2Breast Neoplasms 2Waldenstrom Macroglobulinemia 1Urogenital Neoplasms 1Thrombocythemia, Essential 1Stomach Neoplasms 1Sezary Syndrome 1Sarcoma, Clear Cell 1Prostatic Neoplasms 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Doxorubicin 2selinexor 1pazopanib 1brigimadlin 1Sugars 1Radiotherapy 1Radiation 1Ifosfamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Liposarcoma × Sarcoma × Clear all
NCT02180867 2026-05-04

Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery

National Cancer Institute (NCI)

Phase 2/3 Active not recruiting
140 enrolled 22 charts
Plasma cellSarcoma

Histiocytoma, Angiomatoid Fibrous, Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Granuloma, Plasma Cell, Leiomyosarcoma, Liposarcoma, Sarcoma, Sarcoma, Synovial, Chondrosarcoma, Mesenchymal, Dermatofibrosarcoma, Sarcoma, Clear Cell, Sarcoma, Alveolar Soft Part, Nerve Sheath Neoplasms, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous, Perivascular Epithelioid Cell Neoplasms

NCT05218499 2026-03-02

Brightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma

Boehringer Ingelheim

Phase 2/3 Completed
400 enrolled 15 charts
Sarcoma

Liposarcoma

NCT02606461 2023-01-23

SEAL

Karyopharm Therapeutics Inc

Phase 2/3 Completed
342 enrolled 36 charts
Sarcoma

Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡